We have located links that may give you full text access.
Comparative Study
Journal Article
Comparison of enzyme immunoassay, radioimmunoassay, and microbiologic assay for amikacin in plasma.
American Journal of Hospital Pharmacy 1984 April
An enzyme-multiplied immunoassay technique (EMIT), radioimmunoassay (RIA), and microbiologic assay (MBA) were compared as methods of measuring amikacin in human plasma. Accuracy of the three methods was assessed in plasma with amikacin added in concentrations of 2.5-50 micrograms/ml. Correlations between the assay methods were compared over a range of 0.5-50 micrograms/ml. Amikacin was also assayed in plasma to which had been added other drugs, including 16 antibiotics and 3 antineoplastic agents; also tested were samples that had been stored at 5 degrees C or -20 degrees C. Within the amikacin concentration range of 2.5-50 micrograms/ml, the coefficients of variation of all methods were within 10%. Correlation was good between EMIT and RIA as well as between EMIT and MBA. Of the other drugs tested, only tobramycin, dibekacin, and kanamycin affected amikacin EMIT determinations, while only kanamycin affected amikacin RIA determinations. No effect of cold and freezing was observed on amikacin determinations. EMIT assay is an acceptable method for routine analysis of amikacin plasma samples. The amikacin assay results for the three methods were highly correlated.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app